NCT02106442View on ClinicalTrials.gov

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

CompletedOBSERVATIONAL
Enrollment

579

Participants

Timeline

Start Date

May 13, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Osteoporosis
Interventions
DRUG

Sodium risedronate

Sodium risedronate tablets

Trial Locations (2)

Unknown

Osaka

Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY